Neoadjuvant Chemotherapy and Neoadjuvant Chemotherapy with Immunotherapy Result in Different Tumor Shrinkage Patterns in Triple-negative Breast Cancer

CONCLUSION: Our study demonstrates that the diffuse decrease pattern of tumor shrinkage is more common following NACI than that following NAC. Furthermore, our findings suggest that all tumor shrinkage patterns are associated with a high pCR rate in patients with TNBC treated with NACI.PMID:37985386 | DOI:10.4048/jbc.2023.26.e49
Source: Journal of Breast Cancer - Category: Cancer & Oncology Authors: Source Type: research